Legal & General Group
ACHV icon

Legal & General Group’s Achieve Life Sciences ACHV Stock Holding History

Legal & General Group’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.3K Buy
+7,555
New +$36K ﹤0.01% 2767
2025
Q2 		– Sell
-3,484
Closed -$9.3K – 3418
2025
Q1 		$9.3K Hold
3,484
– – ﹤0.01% 3186
2024
Q4 		$12.3K Hold
3,484
– – ﹤0.01% 3204
2024
Q3 		$16.5K Hold
3,484
– – ﹤0.01% 3124
2024
Q2 		$16.4K Buy
+3,484
New +$16.8K ﹤0.01% 3105

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Legal & General Group's ACHV Position: Q2 2026 in Review

Legal & General Group opened a new position in Achieve Life Sciences (ACHV) in Q2 2026: 7,555 shares worth $49.3K. The stake represents ﹤0.01% of the portfolio and ranks #2767 among its holdings. This is a return to the name: Legal & General Group previously reported a position in ACHV as recently as Q1 2025.

Legal & General Group first reported a position in ACHV in Q2 2024 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Legal & General Group held 7,555 shares of Achieve Life Sciences worth $49.3K as of Q2 2026.
  • Achieve Life Sciences was a new Legal & General Group position in Q2 2026.
  • Achieve Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2767 holding.
  • Legal & General Group first reported a position in Achieve Life Sciences in Q2 2024 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.